Strunk Adam, Bhalla Vikas, Clopton Paul, Nowak Richard M, McCord James, Hollander Judd E, Duc Philippe, Storrow Alan B, Abraham William T, Wu Alan H B, Steg Gabriel, Perez Alberto, Kazanegra Radmila, Herrmann Howard C, Aumont Marie Claude, McCullough Peter A, Maisel Alan
University of California, San Diego, Veterans Affairs San Diego Healthcare System, San Diego, Calif 92161, USA.
Am J Med. 2006 Jan;119(1):69.e1-11. doi: 10.1016/j.amjmed.2005.04.029.
B-type natriuretic peptide is known to correlate with hemodynamic state, presence and severity of congestive heart failure, and prognosis. Although low-range B-type natriuretic peptide less than 100 pg/mL has a high negative predictive value (90%), and high-range B-type natriuretic peptide greater than 500 pg/mL has a high positive predictive value (87%), there remains some ambiguity in the interpretation of results in the medium range (100-500 pg/mL). We hypothesized that taking into account the history of congestive heart failure along with other clinical variables would be helpful in this range of B-type natriuretic peptide levels.
The Breathing Not Properly Multicenter Study was an international, 7-center, prospective study including 1475 patients with a mean age of 63 years (57% were male, and 54% were female); 35% of patients with a history of congestive heart failure were enrolled, and a final diagnosis of congestive heart failure was made in 46%. The index criteria was defined as positive if any 2 index findings (ie, history of coronary artery disease, lower extremity edema, pulmonary edema, cephalization of the pulmonary arteries, and cardiomegaly) were present.
The interval likelihood ratios (LR) for low, medium, and high B-type natriuretic peptide ranges are 0.13, 1.85, and 8.1, respectively. For medium B-type natriuretic peptide levels a positive history of congestive heart failure makes the diagnosis of congestive heart failure more probable with a cumulative LR of 4.3. Also in this range a positive index criterion was strongly indicative of congestive heart failure even in the absence of a history of congestive heart failure (LR 3.3). Where there are both a positive history of congestive heart failure and a positive index criteria for the medium B-type natriuretic peptide group, the cumulative LR (10.2) is similar to that of a high B-type natriuretic peptide level (8.1).
Even in the medium range (100-500 pg/mL), when using the history of congestive heart failure and index criteria, B-type natriuretic peptide can be a powerful diagnostic tool in the hands of clinicians in the emergency department.
已知B型利钠肽与血流动力学状态、充血性心力衰竭的存在及严重程度以及预后相关。尽管低水平的B型利钠肽(低于100 pg/mL)具有较高的阴性预测值(90%),而高水平的B型利钠肽(高于500 pg/mL)具有较高的阳性预测值(87%),但在中等水平范围(100 - 500 pg/mL)的结果解读仍存在一些模糊性。我们推测,结合充血性心力衰竭病史及其他临床变量,对于该B型利钠肽水平范围会有所帮助。
“呼吸不畅”多中心研究是一项国际性、7中心的前瞻性研究,纳入了1475例患者,平均年龄63岁(57%为男性,54%为女性);35%有充血性心力衰竭病史的患者被纳入研究,最终46%的患者被诊断为充血性心力衰竭。如果存在任何两项指标性发现(即冠状动脉疾病史、下肢水肿、肺水肿、肺动脉头征及心脏扩大),则将指标标准定义为阳性。
低、中、高B型利钠肽范围的区间似然比(LR)分别为0.13、1.85和8.1。对于中等B型利钠肽水平,充血性心力衰竭的阳性病史使充血性心力衰竭的诊断更有可能,累积似然比为4.3。同样在此范围内,即使没有充血性心力衰竭病史,阳性指标标准也强烈提示充血性心力衰竭(似然比3.3)。对于中等B型利钠肽组,若既有充血性心力衰竭的阳性病史又有阳性指标标准,累积似然比(10.2)与高水平B型利钠肽(8.1)相似。
即使在中等范围(100 - 500 pg/mL),当使用充血性心力衰竭病史和指标标准时,B型利钠肽在急诊科临床医生手中可以成为一种强大的诊断工具。